Stress and Origins of Hypertension, Including the Robert W. Schrier, MD, Endowed Lectureship
October 24, 2020 | 10:30 AM - 12:30 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
Translational Session
Stress and Origins of Hypertension, Including the Robert W. Schrier, MD, Endowed Lectureship
October 24, 2020 | 10:30 AM - 12:30 PM
Location: Simulive
Session Description
Hypertension is a multifaceted disease with many origins in adulthood. However, the origins of hypertension are also influenced from the lifespan through development, childhood, and adolescence. This session provides current knowledge on these origins of hypertension throughout the lifespan.
ASN gratefully acknowledges Otsuka America Pharmaceutical, Novartis, Astellas Pharma US, and several individuals for support of the Robert W. Schrier, MD, Endowed Lectureship.
Learning Objective(s)
- Describe the novel origins of hypertension
- Discuss potential strategies for prevention of lifespan hypertension
Learning Pathway(s)
Moderators
- Jennifer M. Sasser, PhD
- Michael E. Seifert, MD, MS
Presentations
- Lifespan Hypertension Risk and Birth with One Kidney
10:30 AM - 11:00 AM
Michiel F. Schreuder, MD, PhD
Michiel F. Schreuder, MD, PhD
Michiel Schreuder is associate professor Pediatric Nephrology at the Radboudumc Amalia Children’s Hospital in Nijmegen, the Netherlands. He combines clinical work with research to optimize treatment for children with renal disorders through basic and translational studies and clinical trials. His main research topics are normal and abnormal kidney development, and the nephrotic syndrome. The interaction between the kidney and drugs is one of his interests, ranging from the effect of drugs on kidney development, to dosing recommendations in kidney failure.
Lifespan Hypertension Risk and Birth with One Kidney
October 24, 2020 | 10:30 AM - 11:00 AM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Early Life Stress, Vascular Function, and Hypertension Risk
11:00 AM - 11:30 AM
Jennifer S. Pollock, PhD
Jennifer S. Pollock, PhD
Dr. Jennifer S. Pollock, Endowed Professor of Nephrology, at University of Alabama at Birmingham earning her PhD from UNC-Chapel Hill with postdoctoral training under Dr. Ferid Murad, 1998 Nobel Laureate. Dr. Pollock’s research career involves cardio-renal research focused on the NO and endothelin pathways with her lab instrumental in deciphering mechanisms of early life stress and translating this research to humans. Dr. Pollock has authored over 170 publications with funding from NIH and AHA serving in leadership positions in several societies during her career and mentoring over 75 trainees.
Early Life Stress, Vascular Function, and Hypertension Risk
October 24, 2020 | 11:00 AM - 11:30 AM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- How the Unknown Unknowns Cause Increased Peripheral Vascular Resistance: The Robert W. Schrier, MD, Endowed Lectureship
11:30 AM - 12:00 PM
Friedrich C. Luft, MD, FASN
Friedrich C. Luft, MD, FASN
How the Unknown Unknowns Cause Increased Peripheral Vascular Resistance: The Robert W. Schrier, MD, Endowed Lectureship
October 24, 2020 | 11:30 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Translational Advances in Pediatric Hypertension
12:00 PM - 12:30 PM
Bonita E. Falkner, MD, APN
Bonita E. Falkner, MD, APN
Dr. Bonita Falkner is currently a professor Emeritus of Medicine and Pediatrics at Thomas Jefferson University. Dr. Falkner is a graduate of the University of Minnesota School of Medicine. She is Board Certified in Pediatrics and Pediatric Nephrology. Dr Falkner has been a member of the National Institutes of Health (NIH) Task Force on Blood Pressure Control in Children and Adolescents (Chair), the Joint National Committee on Detection, Evaluation and Treatment of Hypertension, the Working Group on Treatment of Hypertension in Diabetes, and the 2017 Clinical Practice Guidelines on Pediatric Hypertension. She also served on many other national committees, study sections, and working groups to address early detection and prevention of cardiovascular disease.
Dr. Falkner’s research has focused on characterizing preclinical phenotypes of hypertension and cardiovascular disease in the young. She has examined the role of cardiovascular reactivity, sodium sensitivity, ion transport, insulin resistance, obesity, and nutrition as early markers of developing cardiovascular disease, including hypertension and nephropathy. Dr. Falkner’s work has emphasized the unique risk for cardiovascular disease among minority populations, particularly African Americans. She has also investigated preclinical markers for nephropathy. In addition to publications emanating from her basic and clinical investigations, Dr. Falkner has authored many papers which provide guidelines for risk reduction and disease prevention beginning in the young.
Translational Advances in Pediatric Hypertension
October 24, 2020 | 12:00 PM - 12:30 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
